As Rainmaker answered you already quote: FDA Approval of their third test kit and another FDA submission for a fourth test kit. Both are anticipated before the end of the year.
Sgreg mentioned in 1 of his earlier posts quote:
1) GBSN is on the REGsho threshold list. Sellers are not meeting their obligations here. There are significant failures to deliver. Again, probably because they sell shares first before they have even converted.
2) GBSN is also on the REGsho circuit breaker list. Regulators have put in a floor that shorts can not short GBSN below.
This is all about probabilities. I personally believe that the probability as of right now is that there is a greater chance for a bounce then not. Good luck here, this will be a wild one!
Furthermore we stand a great chance for a huge price appreciation within the next 30 days since the A/S is close to being maxed out. They will need a proxy vote to raise the authorized shares, that takes 30 days. For 30 days they cant issue any more shares once the a/s is maxed out at around 200m. The A/S is very close to being maxed out as it seems. Once the a/s is maxed the shorts will have to cover and no more issuance of shares during that 30 day period, therefore forcing the price northbound. GLTUA!!! $$$$GBSN
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.